Filing Details
- Accession Number:
- 0001181431-14-022659
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-04 16:29:17
- Reporting Period:
- 2014-06-02
- Filing Date:
- 2014-06-04
- Accepted Time:
- 2014-06-04 16:29:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375151 | Zogenix Inc. | ZGNX | Pharmaceutical Preparations (2834) | 205300780 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250252 | D Ann Rhoads | C/O Zogenix, Inc. 12400 High Bluff Dr., Suite 650 San Diego CA 92130 | Evp, Cfo, Treasurer & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-06-02 | 17,746 | $2.10 | 471,463 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-03 | 1,464 | $2.03 | 469,999 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-06-03 | 19 | $2.00 | 469,980 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person to cover the taxes payable upon the vesting of 46,000 restricted stock units on June 1, 2014.
- Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.03 to $2.27. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
